{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:27:04Z","timestamp":1765826824154},"reference-count":41,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T00:00:00Z","timestamp":1181606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Objective\u2003<\/jats:bold> To estimate access, activity and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.<\/jats:p><jats:p><jats:bold>Methods\u2003<\/jats:bold> Two data sets (\u2018regional\u2019 and \u2018high\u2010coverage sites\u2019) were used to estimate NSP provision (availability\/number of sites), NSP utilization (syringes distributed\/year), needle and syringe distribution (needles\/syringes distributed\/IDU\/year), IDU reached (number\/percentage of IDU contacted\/year), regular reach (five or more contacts\/month) and syringe coverage (percentage of injections\/IDU\/year administrable with new injecting equipment).<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> Regional data set: results from 213 sites in 25 countries suggested that Czech Republic, Poland, Russia and Ukraine had\u2003&gt;\u200310 NSP during 2001\/2. Czech Republic, Kazakhstan, Latvia, Russia, Slovakia and Ukraine had\u2003\u2265\u200310\u2003000 IDU in contact with NSP. Ten countries reached \u2265\u200310% of the estimated IDU population. The 25 countries distributed \u223c\u200317\u2003million syringes\/needles. Eight countries distributed &gt;\u20030.5\u2003million syringes\/year. Syringe coverage (assuming 400 injections\/IDU\/year) was\u2003&lt;\u20035% in 19 countries, 5\u201315% in five and\u2003&gt;\u200315% in Macedonia. Overall syringe coverage was 1.2% and when assuming 700 injections\/IDU\/year it decreased to 0.7%. Syringe coverage for the IDU population in contact with NSP was\u2003\u2264\u200315% in 10 countries, 15\u201360% in 11 and\u2003&gt;\u200360% in Croatia, Macedonia, Moldova and Tajikistan. Overall syringe coverage for the population in contact with NSP was 9.8%. High\u2010coverage data set: Soligorsk, Pskov and Sumy's NSP reached 92.3%, 92.2% and 73.3% of their estimated IDU population, respectively (regular reach: 0.2%, 1.8% and 22.7%). The distribution levels were 47.2, 51.7 and 94.2 syringes\/IDU\/year, respectively.<\/jats:p><jats:p><jats:bold>Conclusion\u2003<\/jats:bold> The evidence suggests suboptimal levels of NSP implementation, programme activity and coverage. This paper provides a baseline for development of indicators that could be used to monitor NSP. Strategies to increase coverage that may go beyond NSP are urgently required, as is research into understanding how NSP can contribute to better syringe coverage among IDU.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2007.01848.x","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T13:26:08Z","timestamp":1181654768000},"page":"1244-1250","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia*"],"prefix":"10.1111","volume":"102","author":[{"given":"Carmen","family":"Aceijas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.","family":"Donoghoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raminta","family":"Stuikyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,6]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Centers for Disease Control and Prevention.HIV AIDS surveillance report: cases of HIV infection and AIDS in the United States. Atlanta GA:Department of Health and Human Services Public Health Services Centers for Disease Control and Prevention.2002;14:1\u201340."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(05)70321-4"},{"key":"e_1_2_6_4_2","volume-title":"Follow Up to the 2001 UN General Assembly Special Session on HIV\/AIDS. Progress Report on the Global Response to the HIV\/AIDS Epidemic; Injecting Drug Use: Safe Injecting and Sexual Practices.","author":"UNAIDS.","year":"2003"},{"key":"e_1_2_6_5_2","volume-title":"Epidemic Update: December 2000. Regional HIV\/AIDS Statistic and Features End 2000.","author":"UNAIDS.","year":"2000"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411190-00010"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826080600669579"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02536-6"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11380-5"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200210010-00015"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530150050033"},{"key":"e_1_2_6_12_2","first-page":"S71","article-title":"Can HIV epidemics among injection drug users be prevented?","volume":"12","author":"Strathdee S. A.","year":"1998","journal-title":"AIDS"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(03)00133-6"},{"key":"e_1_2_6_14_2","volume-title":"Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV\/AIDS Among Injecting Drug Users Geneva.","author":"World Health Organization (WHO).","year":"2004"},{"key":"e_1_2_6_15_2","volume-title":"Global crisis\u2014global action","author":"United Nations (UN) Special Session on HIV\/AIDS (UNGASS).","year":"2001"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.16.3.264.35436"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.9611163910.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2003.033563"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jth113"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000127054.60503.9a"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2003.08.001"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/002204269902900407"},{"key":"e_1_2_6_23_2","article-title":"Global estimates on IDU prevalence, VHI and availability of needle exchange programs","author":"Hickman M.","year":"2004","journal-title":"Proceedings of the International Conference on Syringe Exchange"},{"key":"e_1_2_6_24_2","volume-title":"The State of the Drugs Problem in Europe.","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).","year":"2005"},{"key":"e_1_2_6_25_2","first-page":"1","volume-title":"HIV\/AIDS in Europe. Moving from Death Sentence to Chronic Disease Management.","author":"Srdan M.","year":"2006"},{"key":"e_1_2_6_26_2","unstructured":"Central and Eastern European Harm Redution Network (CEEHRN).Inventory of syringe exchange and outreach projects in Central and Eastern Europe and the Commonwealth of Independent States.2003. Available at:http:\/\/www.ceehrn.org\/maps2(accessed 26 July 2006)."},{"issue":"3","key":"e_1_2_6_27_2","first-page":"10","article-title":"Estimates of injecting drug users at the national and local level in developing and transitional countries and gender and age distribution.","volume":"82","author":"Aceijas C.","year":"2006","journal-title":"Sex Transm Infect"},{"key":"e_1_2_6_28_2","unstructured":"WeissingL.Estimating Coverage of Harm\u2010Reduction Measures for Injecting Drug Users in Europe. NIDA\/Global Research Network on HIV in Drug Using Populations.Third annual meeting 2000."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826080600667201"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(00)00109-X"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000219788.73539.47"},{"key":"e_1_2_6_32_2","volume-title":"Situation with the Spread of Injection Drug Use and HIV in the Republic of Belarus","author":"Belarus National AIDS Centre.","year":"2001"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00128.x"},{"key":"e_1_2_6_34_2","first-page":"405","article-title":"Between\u2010city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico","volume":"27","author":"Colon H. M.","year":"2001","journal-title":"J AIDS"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952999809001715"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(94)90136-8"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01171-9"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.95340711.x"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.18356\/1f8caff1-en"},{"key":"e_1_2_6_40_2","unstructured":"United Nations Office on Drug and Crime (UNODC).Who Is Using Drugs?2006. Available at:http:\/\/www.unodc.org\/unodc\/en\/drug_demand_who.html(accessed 28 February 2007)."},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00800.x"},{"key":"e_1_2_6_42_2","first-page":"673","article-title":"Update: Syringe Exchange Programs\u2014United States, 2002","volume":"54","author":"Centers for Disease Control and Prevention (CDC).","year":"2005","journal-title":"MMWR"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2007.01848.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2007.01848.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:38:00Z","timestamp":1697521080000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2007.01848.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,6]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1360-0443.2007.01848.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2007.01848.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,6]]},"assertion":[{"value":"2007-07-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}